Home
>
National Drug Code (NDC)
>
Valsartan and Hydrochlorothiazide
Valsartan and Hydrochlorothiazide - 33342-076-10 - (Valsartan and Hydrochlorothiazide)
Drug Information of Valsartan and Hydrochlorothiazide
| Product NDC: | 33342-076 |
| Proprietary Name: | Valsartan and Hydrochlorothiazide |
| Non Proprietary Name: | Valsartan and Hydrochlorothiazide |
| Active Ingredient(s): | 25; 160 mg/1; mg/1 & nbsp; Valsartan and Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Valsartan and Hydrochlorothiazide
| Product NDC: | 33342-076 |
| Labeler Name: | Macleods Pharmaceuticals Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA203145 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130419 |
Package Information of Valsartan and Hydrochlorothiazide
| Package NDC: | 33342-076-10 |
| Package Description: | 90 TABLET in 1 BOTTLE (33342-076-10) |
NDC Information of Valsartan and Hydrochlorothiazide
| NDC Code | 33342-076-10 |
| Proprietary Name | Valsartan and Hydrochlorothiazide |
| Package Description | 90 TABLET in 1 BOTTLE (33342-076-10) |
| Product NDC | 33342-076 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Valsartan and Hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130419 |
| Marketing Category Name | ANDA |
| Labeler Name | Macleods Pharmaceuticals Limited |
| Substance Name | HYDROCHLOROTHIAZIDE; VALSARTAN |
| Strength Number | 25; 160 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
